A selective cooxygenase-2 inhibitor for injection: parecoxib sodiumCUI Xiang-li, ZHAO Zhi-gang, CHEN Li, LI Ming1283-1286
Communication to the Public Guidance of FDA's Drug Safety Information and the inspiration to our countryWEI Jing, PAN Wei-san, YANG Yue1287-1290
International comparison of the monitoring systems of drug safety in clinical trialsXU Bo, WANG Yan1291-1293
Considerations for current evaluation for nonclinical safety of compound preparations from traditional Chinese medicineZHANG Xiao-dong, HAN Ling, ZHU Fei-peng1294-1296,1315
Influence of genetic polymorphisms on the pharmacokinetics of tacrolimus in patients with organ transplantationWANG Hua-ming, HU Yong-fang1300-1303
Advance in pharmaceutical studies of expandable gastroretentive dosage formsTANG Yu, LUO Jie-ying, WANG Wen-ping, LIU Cha, HE Fu-yuan, YANG Da-jian1304-1307,1311
Effect of Chaihu-Taoren Tang on tardive dyskinesia and the possible mechanismZHANG Xing-li, TAN Yun-long, SU Jian-min, YANG Fu-de, JI Zhong-fu, ZHOU Dong-feng1312-1315